Long-term Outcomes of Surgery for Metastatic and Recurrent Gastrointestinal Stromal Tumours in the Tyrosine Kinase Inhibitor Era: A 14-Year Single-Centre Experience from a Tertiary Cancer Centre in India
Long-term Outcomes of Surgery for Metastatic and Recurrent Gastrointestinal Stromal Tumours in the Tyrosine Kinase Inhibitor Era: A 14-Year Single-Centre Experience from a Tertiary Cancer Centre in India. // Journal of Gastrointestinal Surgery. – URL: https://www.sciencedirect.com/science/article/pii/S1091255X26002921?dgcid=rss_sd_all
Long-term Outcomes of Surgery for Metastatic and Recurrent Gastrointestinal Stromal Tumours in the Tyrosine Kinase Inhibitor Era: A 14-Year Single-Centre Experience from a Tertiary Cancer Centre in India. Journal of Gastrointestinal Surgery. https://www.sciencedirect.com/science/article/pii/S1091255X26002921?dgcid=rss_sd_all
“Long-term Outcomes of Surgery for Metastatic and Recurrent Gastrointestinal Stromal Tumours in the Tyrosine Kinase Inhibitor Era: A 14-Year Single-Centre Experience from a Tertiary Cancer Centre in India.” Journal of Gastrointestinal Surgery.
@article{article100722,
title = {Long-term Outcomes of Surgery for Metastatic and Recurrent Gastrointestinal Stromal Tumours in the Tyrosine Kinase Inhibitor Era: A 14-Year Single-Centre Experience from a Tertiary Cancer Centre in India},
journal = {Journal of Gastrointestinal Surgery},
url = {https://www.sciencedirect.com/science/article/pii/S1091255X26002921?dgcid=rss_sd_all}
}